10-Q Filing

XILIO THERAPEUTICS, INC. CIK: 1840233 Q1 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-008441`
Period End Date	20220331
Filing Date	20220512
Fiscal Year	2022
Fiscal Period	Q1
XBRL Instance	xlo-20220331x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 24 Cash Flow Statement 46 Stockholders Equity 15

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$198.05M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.22M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$176.96M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.13M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.46M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$181.09M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$202.52M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$1.55M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.47M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.47M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$7.62M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.36M	shares	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.88M	USD	Point-in-time
Operating lease right-of-use asset	`OperatingLeaseRightOfUseAsset`	$5.98M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.38M	shares	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$393.00K	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$359.00K	USD	Point-in-time
Total assets	`Assets`	$218.06M	USD	Point-in-time
Total assets	`Assets`	$196.35M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.32M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$7.32M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$8.75M	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$801.00K	USD	Point-in-time
Operating lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$829.00K	USD	Point-in-time
Notes payable, current portion	`NotesPayableCurrent`	$1.67M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$82.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.22M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$8.01M	USD	Point-in-time
Notes payable, net of current portion	`LongTermNotesPayable`	$9.63M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$9.89M	USD	Point-in-time
Operating lease liability, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$10.11M	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$100.00K	USD	Point-in-time
Other liabilities, long-term	`OtherLiabilitiesNoncurrent`	$118.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$32.63M	USD	Point-in-time
Total liabilities	`Liabilities`	$30.23M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.0001 par value; 5,000,000 shares authorized, no shares issued or outstanding at March 31, 2022 and December 31, 2021	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2022 and December 31, 2021; 27,471,607 shares issued and 27,376,473 shares outstanding at March 31, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2022 and December 31, 2021; 27,471,607 shares issued and 27,376,473 shares outstanding at March 31, 2022; 27,468,950 shares issued and 27,358,375 shares outstanding at December 31, 2021	`CommonStockValue`	$3.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$348.36M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$346.31M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-160.89M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-182.24M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$166.12M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$185.43M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-99.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$196.35M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$218.06M	USD	Point-in-time

Income Statement 24 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$14.92M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$11.62M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.90M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.30M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$16.52M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$21.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-21.22M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-16.52M	USD	1 Quarter
Other expense, net	`OtherNonoperatingExpense`	$129.00K	USD	1 Quarter
Other expense, net	`OtherNonoperatingExpense`	$147.00K	USD	1 Quarter
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-147.00K	USD	1 Quarter
Total other expense, net	`OtherNonoperatingIncomeExpense`	$-129.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.67M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.67M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.35M	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-23.53	USD	1 Quarter
Net loss per share, basic (in dollars per share)	`EarningsPerShareBasic`	$-0.78	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.78	USD	1 Quarter
Net loss per share, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-23.53	USD	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	708,264.00	shares	1 Quarter
Weighted average common shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	27.37M	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	708,264.00	shares	1 Quarter
Weighted average common shares outstanding, diluted (in shares)	`WeightedAverageNumberDilutedSharesOutstandingAdjustment`	27.37M	shares	1 Quarter

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.67M	USD	1 Quarter
Net loss	`ProfitLoss`	$-21.35M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$440.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$350.00K	USD	1 Quarter
Non-cash interest expense	`NoncashInterestExpense`	$38.00K	USD	1 Quarter
Non-cash interest expense	`NoncashInterestExpense`	$53.00K	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$2.03M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$794.00K	USD	1 Quarter
Change in fair value of warrant and derivative liabilities	`FairValueAdjustmentsOfWarrantsAndDerivativeLiabilities`	$15.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-153.00K	USD	1 Quarter
Prepaid and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-336.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-78.00K	USD	1 Quarter
Operating lease right-of-use asset	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-92.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-2.84M	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-820.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-1.43M	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-4.63M	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-185.00K	USD	1 Quarter
Operating lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-30.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-22.73M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-20.84M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$254.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$170.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-254.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-170.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Payments of finance lease	`FinanceLeasePrincipalPayments`	$21.00K	USD	1 Quarter
Proceeds from issuance of convertible preferred stock, net of issuance costs	`ProceedsFromIssuanceOfConvertiblePreferredStock`	$144.89M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$25.00K	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$16.00K	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$144.89M	USD	1 Quarter
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-5.00K	USD	1 Quarter
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$121.99M	USD	1 Quarter
(Decrease) increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-21.09M	USD	1 Quarter
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.78M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$199.61M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.79M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$178.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.78M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$125.00K	USD	1 Quarter
Cash paid for interest	`InterestPaidNet`	$119.00K	USD	1 Quarter
Capital expenditures included in accounts payable or accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$249.00K	USD	1 Quarter
Deferred offering costs included in accounts payable or accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableOrAccruedExpenses`	$201.00K	USD	1 Quarter

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Beginning balance	`StockholdersEquity`	$-99.14M	USD	Point-in-time
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$16.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$25.00K	USD	1 Quarter
Exercise of stock options (in shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	2,657.00	shares	1 Quarter
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.03M	USD	1 Quarter
Equity-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$794.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.67M	USD	1 Quarter
Ending balance	`StockholdersEquity`	$166.12M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$185.43M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-83.29M	USD	Point-in-time
Ending balance	`StockholdersEquity`	$-99.14M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.